Back
ProShares S&P Kensho Cleantech ETF Vs. Rigel Pharmaceuticals, Inc. Sector Stock Comparison
Sell
50
CTEX
ProShares S&P Kensho Cleantech ETF
Last Price:
$36.65
Seasonality Move:
-8.49%
Buy
72
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.63
Seasonality Move:
-1.35%
Sell
50
ProShares S&P Kensho Cleantech ETF (CTEX)
is a Sell
Is ProShares S&P Kensho Cleantech ETF a Buy, Sell or Hold?
-
The current ProShares S&P Kensho Cleantech ETF [CTEX] share price is $36.33. The Score for CTEX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
CTEX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $41.77. The Score for RIGL is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CTEX Stock Price Chart
What is ProShares S&P Kensho Cleantech ETF's stock price today?
-
The ProShares S&P Kensho Cleantech ETF share price today is $36.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTEX is experiencing selling pressure, which indicates risk of future bearish movement.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $41.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
CTEX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 51.26 | Buy |
| Chaikin Money Flow: | -1550 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.65 - 37.17) | Buy |
| Bollinger Bands (100): | (26.81 - 36.75) | Buy |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.92 | Buy |
| Relative Strength Index (14 RSI): | 48.84 | Sell |
| Chaikin Money Flow: | -387889 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.3 - 48) | Sell |
| Bollinger Bands (100): | (28.82 - 43.02) | Buy |
CTEX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.98 | Sell |
| 20-day SMA: | 35.61 | Buy |
| 50-day SMA: | 36.09 | Buy |
| 200-day SMA: | 25.72 | Buy |
| 8-day EMA: | 36.47 | Sell |
| 20-day EMA: | 36.21 | Buy |
| 50-day EMA: | 34.63 | Buy |
| 200-day EMA: | 20.85 | Buy |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.82 | Sell |
| 20-day SMA: | 45.2 | Sell |
| 50-day SMA: | 37.87 | Buy |
| 200-day SMA: | 27.55 | Buy |
| 8-day EMA: | 16.53 | Buy |
| 20-day EMA: | 7.59 | Buy |
| 50-day EMA: | 3.22 | Buy |
| 200-day EMA: | 0.83 | Buy |
ProShares S&P Kensho Cleantech ETF Earnings Growth & CTEX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
ProShares S&P Kensho Cleantech ETF Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||